AbbVie provided an optimistic outlook for 2025, with an adjusted EPS guidance range of $12.12 to $12.32 and total net revenues expected to reach $59 billion. The company anticipates significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback